Compounds as GLP-1R agonists
US12024507B2 · kind B2 · utility
5Cited by
6References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 25, 2022 |
| Grant date | Jul 2, 2024 |
| Priority date | — |
| Expiry date | Oct 25, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application provides compounds that may be used as a glucagon-like peptide-1 receptors (GLP-1R) agonist, or pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions containing such compounds, or pharmaceutically acceptable salts thereof. Methods of preparing these compounds and compositions, and methods of using these compounds and compositions to treat or prevent a disease or a condition mediated by GLP-1R, are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.